CompletedNot Applicable

Hashtag HPV: HPV Vaccine Twitter Education Program

United States28 participantsStarted 2021-12-13

Plain-language summary

Parents use social media as an important parenting tool and source for health information. Using social media data to examine public opinion has had an early impact in public health and in cancer control and prevention efforts, including about the human papillomavirus (HPV) vaccine. A next step in this area of research is to develop and share messages on social media with parents to help inform and educate them about the HPV vaccine - ultimately assisting them with their decision to vaccinate their child. This study will evaluate the efficacy of social media messages through Twitter, using a randomized controlled trial to determine what types of messages resonate with parents. The investigators will examine differences between two types of messages - narrative messages (i.e., stories) and non-narrative messages (i.e., numbers and facts).

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Adults 18 years of age and older;
. Utilizes Twitter, a social media platform;
. Has a child aged 9-14;
. Child has not started the 2-dose HPV vaccination series;
. Has no child who has completed any dose HPV vaccination series;
. Has a well-care visit scheduled for their child before December, 2022.

Exclusion criteria

. Any adult who does not have a child 9-14 years of age;

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in caregiver self-reported HPV vaccination status of child questionnaire

Timeframe: Change in caregiver self-reported HPV vaccination of child at 1-month follow-up from baseline

Change in caregiver self-reported HPV vaccination status of child questionnaire

Timeframe: Change in caregiver self-reported HPV vaccination of child at 1-year follow-up from 1-month follow-up

Trial details

NCT IDNCT05204030

SponsorUniversity of Arkansas, Fayetteville

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-02-29

View on ClinicalTrials.gov More Human Papilloma Virus trials

Plain-language summary

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Adults 18 years of age and older;
. Utilizes Twitter, a social media platform;
. Has a child aged 9-14;
. Child has not started the 2-dose HPV vaccination series;
. Has no child who has completed any dose HPV vaccination series;
. Has a well-care visit scheduled for their child before December, 2022.

Exclusion criteria

. Any adult who does not have a child 9-14 years of age;

What they're measuring

Change in caregiver self-reported HPV vaccination status of child questionnaire

Timeframe: Change in caregiver self-reported HPV vaccination of child at 1-month follow-up from baseline

Change in caregiver self-reported HPV vaccination status of child questionnaire

Timeframe: Change in caregiver self-reported HPV vaccination of child at 1-year follow-up from 1-month follow-up